Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

NCT00427765

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

NCT00095381

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Los Angeles, California, United States

Palo Alto, California, United States

Denver, Colorado, United States

Gainesville, Florida, United States

View all 24 locations

View Trial Details

Completed

A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma

NCT00636792

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

MidDakota Clinic - Cancer Treatment and Research Center Bismarck, North Dakota, United States

View Trial Details

Completed

PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT00048230

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

City of Hope Duarte, California, United States

Scripps Clinic La Jolla, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

View all 93 locations

View Trial Details

Completed

A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

NCT00063726

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas Medical Sciences Little Rock, Arkansas, United States

Alta Bates Comprehensive Cancer Center Berkeley, California, United States

City of Hope Duarte, California, United States

Scripps Clinic, Green Cancer Center La Jolla, California, United States

View all 76 locations

View Trial Details

Completed

Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia

NCT00723346

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Hopital Debrousse Lyon, France

View Trial Details

Completed

Aerobic and Strengthening Exercise for Acute Leukemia

NCT00766311

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Oregon Health and Science University Portland, Oregon, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)

NCT00505232

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital Marques de Valdecilla Santander, Cantabria, Spain

Hospital del Mar Barcelona, Catalonia, Spain

Hospital Clínico de Santiago de Compostela Santiago de Compostela, Galica, Spain

View all 16 locations

View Trial Details

Completed

Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma

NCT00935844

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

Karmanos Cancer Center Detroit, Michigan, United States

Fox Chase Cancer Center Rockledge, Pennsylvania, United States

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions